HIGHLIGHTS
- who: Masami Miki and collaborators from the Department of Hepato-Biliary-Pancreatology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University have published the research work: Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study, in the Journal: (JOURNAL) of 28/02/2022
- what: The authors conducted a multicenter prospective analysis to assess the therapeutic effects and safety of nal-IRI/FF in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.